D
DiaMedica Therapeutics D
D
DMAC
4.29000
USD
-0.11
(-2.50%)
Market Closed
Volume
2,316
EPS
0
Div Yield
0
P/E
-8
Market Cap
183,388,199
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks newsTitle: DiaMedica Therapeutics
Sector: Healthcare
Industry: Biotechnology
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.